Piper Sandler Raises AbbVie (ABBV) Price Target to $289, Maintains Overweight Rating

AbbVie Inc. (NYSE:ABBV) is included among the 15 Best DRIP Stocks to Own Right Now. On November 5, Piper San‍dler​ analyst David Amsellem raised the price...

Read Full Article →